PRDM16是维持左心室致密心肌细胞身份所需的致密心肌富集转录因子
本研究通过构建心肌细胞特异性Prdm16敲除小鼠,发现其可再现患者左心室非致密化心肌病(LVNC)的左心室扩张、功能障碍及双室非致密化表型。PRDM16作为致密心肌富集转录因子,激活致密心肌基因并抑制小梁心肌基因,其缺失使左心室致密心肌细胞转录身份向小梁心肌或神经元样转变,部分通过协同左心室富集转录因子Tbx5和Hand1实现。
要点
- 心肌细胞特异性Prdm16敲除小鼠再现LVNC的左心室扩张、功能障碍和双室非致密化。
- PRDM16在左心室致密心肌中激活致密心肌基因并抑制小梁心肌基因。
- PRDM16缺失使致密心肌细胞转录组向小梁心肌或神经元样身份转变。
核心结论
- 致密心肌细胞规格制定异常可能是LVNC发病的关键机制。
研究设计与样本
- 研究构建并分析心肌细胞特异性Prdm16敲除(Prdm16cKO)小鼠的心脏表型。
- 采用RNA测序和染色质免疫沉淀测序鉴定PRDM16在心肌细胞中的直接转录靶点。
- 采用单细胞RNA测序结合空间转录组学在单细胞水平确定心肌细胞身份。
主要发现
- Prdm16cKO小鼠出现左心室特异性扩张和功能障碍,以及双室非致密化,完全再现患者LVNC。
- PRDM16作为致密心肌富集转录因子,激活致密心肌基因并抑制左心室致密心肌中的小梁心肌基因。
- Prdm16cKO左心室致密心肌细胞的转录身份从正常状态转向类似小梁心肌细胞或神经元的特征。
- PRDM16对心腔特异性转录调控部分归因于与左心室富集转录因子Tbx5和Hand1的协同作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular noncompaction cardiomyopathy (LVNC) was discovered half a century ago as a cardiomyopathy with excessive trabeculation and a thin ventricular wall. In the decades since, numerous studies have demonstrated that LVNC primarily has an effect on left ventricles (LVs) and is often associated with LV dilation and dysfunction. However, in part because of the lack of suitable mouse models that faithfully mirror the selective LV vulnerability in patients, mechanisms underlying the susceptibility of LVs to dilation and dysfunction in LVNC remain unknown. Genetic studies have revealed that deletions and mutations in PRDM16 (PR domain-containing 16) cause LVNC, but previous conditional Prdm16 knockout mouse models do not mirror the LVNC phenotype in patients, and the underlying molecular mechanisms by which PRDM16 deficiency causes LVNC are still unclear. METHODS: Prdm16 cardiomyocyte-specific knockout (Prdm16cKO) mice were generated and analyzed for cardiac phenotypes. RNA sequencing and chromatin immunoprecipitation deep sequencing were performed to identify direct transcriptional targets of PRDM16 in cardiomyocytes. Single-cell RNA sequencing in combination with spatial transcriptomics was used to determine cardiomyocyte identity at the single-cell level. RESULTS: Cardiomyocyte-specific ablation of Prdm16 in mice caused LV-specific dilation and dysfunction, as well as biventricular noncompaction, which fully recapitulated LVNC in patients. PRDM16 functioned mechanistically as a compact myocardium-enriched transcription factor that activated compact myocardial genes while repressing trabecular myocardial genes in LV compact myocardium. Consequently, Prdm16cKO LV compact myocardial cardiomyocytes shifted from their normal transcriptomic identity to a transcriptional signature resembling trabecular myocardial cardiomyocytes or neurons. Chamber-specific transcriptional regulation by PRDM16 was attributable in part to its cooperation with LV-enriched transcription factors Tbx5 and Hand1. CONCLUSIONS: These results demonstrate that disruption of proper specification of compact cardiomyocytes may play a key role in the pathogenesis of LVNC. They also shed light on underlying mechanisms of the LV-restricted transcriptional program governing LV chamber growth and maturation, providing a tangible explanation for the susceptibility of LV in a subset of LVNC cardiomyopathies.
引用
- Wu T, Liang Z, Zhang Z, et al. PRDM16 Is a Compact Myocardium-Enriched Transcription Factor Required to Maintain Compact Myocardial Cardiomyocyte Identity in Left Ventricle. Circulation. 2021. PMID: 34915728. doi:10.1161/CIRCULATIONAHA.121.056666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。